Merging traditional and contemporary musculoskeletal pathology — USCAP 2025
The musculoskeletal pathology course 2025 from USCAP examines non-neoplastic and neoplastic diseases of bones and joints alongside a spectrum of soft tissue neoplasms. For bone and joint entities, the focus lands on common conditions that create diagnostic challenges across practice settings — the aim being to raise diagnostic confidence. For soft tissue neoplasms, the course evaluates recent changes in diagnostic criteria and newly clarified entities that directly affect patient management. Released April 14, 2025, the course serves practicing academic and community pathologists as well as pathologists-in-training.
-
2025edition
-
3disease areas
Inside this resource
Bone and joint diagnostic challenges
The course tackles entities that trip up pathologists regardless of practice setting — conditions where morphology alone can be misleading without proper clinical and radiographic correlation. Each disease reviewed includes the most current histologic criteria and, where applicable, the radiographic features that sharpen the differential. The emphasis on common entities rather than rare curiosities makes this immediately applicable to daily sign-out.
Soft tissue neoplasms — updated criteria and new entities
Since the prior USCAP Long Course on this topic, several soft tissue entities have been further clarified and diagnostic criteria have shifted. The faculty address these changes head-on, walking through the histologic and molecular features that distinguish newly recognized entities from their mimics. This section bridges the gap between the published literature and what you actually encounter on the slide.
Molecular testing and ancillary techniques
Molecular testing, immunohistochemistry, and other ancillary techniques are integrated throughout — not as separate lectures but woven into each disease discussion. The course also covers exciting emerging changes in ancillary methods that are anticipated to soon impact clinical management, giving you a forward-looking perspective on where MSK pathology diagnostics are headed.
Who this serves
- Academic pathologists — updated criteria and molecular integration for bone, joint, and soft tissue diagnosis
- Community pathologists — practical diagnostic confidence for the MSK entities encountered most often
- Pathologists-in-training — foundational approach to MSK pathology with contemporary methods
Before you buy
Is this a recorded course?
Yes — this is the recorded version of the USCAP 2025 Annual Meeting Long Course, available for on-demand viewing.
Does it cover pediatric bone pathology?
The primary focus is on common diagnostic challenges across adult bone, joint, and soft tissue pathology, with emphasis on entities that create difficulty in both academic and community settings.
The chart
| Format | Video lectures |
|---|---|
| Year | 2025 (released April 14) |
| Publisher | USCAP |
| Department | Orthopedics |
| Delivery | Instant download after checkout · lifetime re-access |
Verified original fileInstant downloadEncrypted checkout



David C. –
Good content covering the bread-and-butter of MSK pathology. The updated histologic criteria for soft tissue entities were well-presented. The course moves quickly through some complex topics but the recordings allow pausing and review.
Patricia W. –
Exactly the kind of MSK pathology update I needed. The soft tissue neoplasm section with the new diagnostic criteria was outstanding. Molecular testing woven into each disease discussion is the right approach.
Hiroshi K. –
Solid overview of bone and joint pathology with practical diagnostic tips. The radiographic correlation sections are especially helpful for correlating slides with imaging. Could use more case-based examples in the bone tumor section.
Linda M. –
This is my go-to reference for the MSK entities that trip me up in sign-out. The emerging ancillary techniques section gives a nice preview of where the field is heading. Highly recommended for community pathologists.
Amira S. –
Outstanding integration of molecular testing throughout the course rather than as an afterthought. The faculty do a great job connecting slide morphology to clinical management decisions. Essential for any pathologist signing out MSK material.